DLE

DLE is part of Fleury’s Group, one of the largest and most respected health organizations in Brazil, renowned for its technical, medical, service, and management quality, serving as a reference for the medical community and the general public. Our expertise in specialized laboratory routines enables us to create tailored solutions for specific diagnostic programs. We utilize cutting-edge technology and highly qualified professionals to meet your expectations, allowing you to focus on providing medical care.

DLE has pioneered various diagnostic methodologies, including tandem mass spectrometry for neonatal screening and inborn errors of metabolism, capillary electrophoresis for neonatal hemoglobinopathy testing, and NGS (Next Generation Sequencing) for gene sequencing. These methodologies are crucial for patient safety, enabling early diagnostics and cost-effective healthcare.

Fleury’s Group upholds ethical standards and is the first laboratory in Latin America to achieve CAP ISO 15819 Accreditation. We also hold several accreditations such as ERNDIM (Quality Assurance in Laboratory Testing for IEM), RCPA (Royal College of Pathologists of Australasia), SKML (Stichting Kwaliteitsbewaking Medische Laboratoriumdiagnostiek), and others.